Guardant Health
GH
#1787
Rank
A$16.14 B
Marketcap
A$123.10
Share price
-3.96%
Change (1 day)
71.81%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Guardant Health (GH) - Cash on Hand

Cash on Hand as of December 2025 : A$1.74 Billion

According to Guardant Health 's latest financial reports the company has A$1.74 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Guardant Health - Cash on Hand chart (from 2017 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2025-12-31A$1.79 B32.84%
2024-12-31A$1.35 B-21.27%
2023-12-31A$1.71 B15.43%
2022-12-31A$1.48 B15.5%
2021-12-31A$1.28 B-44.88%
2020-12-31A$2.33 B212.61%
2019-12-31A$0.74 B25.56%
2018-12-31A$0.59 B109.78%
2017-12-31A$0.28 B114.52%
2016-12-31A$0.13 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Neogen
NEOG
A$0.21 B-87.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
A$1.56 B-10.44%๐Ÿ‡บ๐Ÿ‡ธ USA